Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02002026
NCT02002026
Completed
Not Applicable

Uterine Artery Ligation to Minimize Blood Loss in Patients With Central Placenta Previa

Minia Maternity University Hospital1 site in 1 country52 target enrollmentNovember 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPlacenta Previa Without Hemorrhage

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Placenta Previa Without Hemorrhage
Sponsor
Minia Maternity University Hospital
Enrollment
52
Locations
1
Primary Endpoint
Changes in hemoglobin level
Status
Completed
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This trial will address the effect of uterine artery ligation during Cesarean section in cases with placenta previa to decrease blood loss.

Detailed Description

This Study will address the effect of uterine artery ligation prior to fetal delivery during Cesarean section in cases with central placenta previa to guard against postpartum hemorrhage and to minimize blood loss.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
November 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Minia Maternity University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ahmad Sameer Sanad

Assistant Professor

Minia Maternity University Hospital

Eligibility Criteria

Inclusion Criteria

  • •Placenta previa is diagnosed when the lowest placental edge is located within 5 cm of the internal os at ultrasound
  • •Symptomatic Placenta previa with at least one episode of bleeding
  • •Estimated gestational age within 28 to 40 weeks
  • •Maternal age \> 18 years
  • •Informed consent
  • •Social affiliation

Exclusion Criteria

  • •Premature rupture of membranes
  • •Severe bleeding.
  • •Abnormal fetal heart rates.
  • •Pre-eclampsia, chorioamnionitis, severe chronic renal disease.

Outcomes

Primary Outcomes

Changes in hemoglobin level

Time Frame: hemoglobin level will be done baseline and will be repeated 24 hours after delivery

Changes in hemoglobin level before and after CS will reflect the amount of blood loss during operation

Secondary Outcomes

  • Degree of uterine contractility.(During CS and within 3 hours after CS)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Temporary Clipping of the Uterine Arteries During Laparoscopic MyomectomyLeiomyomaLaparoscopic Myomectomy
NCT01530802Charite University, Berlin, Germany166
Recruiting
Not Applicable
Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled TrialFibroid Uterus
NCT06269809Universitaire Ziekenhuizen KU Leuven82
Unknown
Not Applicable
Bilateral Uterine Artery Ligation in PPC Technique for Management of PASPlacenta Accreta
NCT05314595Assiut University130
Completed
Not Applicable
Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean SectionPost Partum Hemorrhage
NCT03591679Assiut University1,070
Recruiting
Not Applicable
Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef UniversityPlacenta Accreta
NCT06465836Nesreen Abdel Fattah Abdullah Shehata172